Skip to main content
IDWeek 2022 Main banner
Save the Date IDWeek 2023
IDWeek 2022 On Demand
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Watch the live stream on the conference website.
Watch the live stream on the conference website.
ViewAttendees 1

Session: Late Breaking Abstracts: A Tour of ID Topics

LB1580 - Efficacy Assessment of MAT2203 Encochleated Oral Formulation of Amphotericin B, in the Neutropenic Mouse Model of Pulmonary Mucormycosis

Friday, October 21, 2022
4:03 PM - 4:15 PM US ET
Location: 204 ABC
Watch the live stream on the conference website.
All relevant financial disclosures have been mitigated.

    Co-Author(s)

  • TG

    Teclegiorgis Gebremariam, M.S.

    Research Associate
    The Lundquist Institute at Harbor-UCLA Medical Center
    Torrance, California, United States

    Disclosure(s): No financial relationships to disclose

  • Yiyou Gu, PhD

    Postdoctoral fellow
    The Lundquist Institute at Harbor-UCLA Medical Center
    Torrance, California, United States

    Disclosure(s): No financial relationships to disclose

  • SA

    Sondus Alkhazraji, PhD

    The Lundquist Institute at Harbor-UCLA Medical Center
    Torrance, California, United States

    Disclosure(s): No financial relationships to disclose

  • Eman youssef, PHD

    Postdoctoral fellow
    The LUndquist Institute
    Torrance, California, United States

    Disclosure(s): No financial relationships to disclose

  • Theresa Matkovits, PhD (she/her/hers)

    Chief Development Officer
    Matinas BioPharma
    Bedminster, New Jersey, United States

    Disclosure(s): Matinas BioPharma: Employee ()

  • JC

    Jenel Cobb, PhD

    Matinas BioPharma
    Bedminster, New Jersey, United States

    Disclosure(s): Matinas BioPharma: Employee ()

  • Raphael J. Mannino, PhD

    Chief Scientific Officer
    Matinas BioPharma
    Bedminster, New Jersey, United States

    Disclosure(s): Matinas BioPharma: Employee ()

    • Presenting Author(s)

  • Ashraf S. Ibrahim, PhD

    Professor of Medicine
    The Lundquist Institute at Harbor-UCLA Medical Center
    Torrance, CA, United States

    Disclosure(s): Matinas BioPharma: Advisor/Consultant (), Grant/Research Support (); SFunga: Grant/Research Support ()

    Slides
Disclosure(s):
Teclegiorgis Gebremariam, M.S.: No financial relationships to disclose
Yiyou Gu, PhD: No financial relationships to disclose
Sondus Alkhazraji, PhD: No financial relationships to disclose
Eman youssef, PHD: No financial relationships to disclose
Theresa Matkovits, PhD: Matinas BioPharma: Employee ()
Jenel Cobb, PhD: Matinas BioPharma: Employee ()
Raphael J. Mannino, PhD: Matinas BioPharma: Employee ()
Ashraf S. Ibrahim, PhD: Matinas BioPharma: Advisor/Consultant (), Grant/Research Support (); SFunga: Grant/Research Support ()